Recent research indicates that interventions such as PPAR-γ agonists like pioglitazone, gastric bypass surgery, and lifestyle modifications involving diet and physical activity can significantly reduce fetuin-A levels, offering multifaceted avenues for managing T2DM [90-92]. The gene discussed is AHSG; the disease is type 2 diabetes mellitus.